| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $256.7M | +99.9% |
| R&D Expense | $79.6M | +53.7% |
| SG&A Expense | $122.3M | +68.5% |
| Pre-tax Income | -$294.8M | -26.2% |
| Income Tax | $3.0M | -61.0% |
| Net Income | -$297.8M | -23.4% |
| EPS (Basic) | -$4.59 | -16.5% |
| EPS (Diluted) | -$4.59 | -16.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $282.5M | +4.4% |
| Short-term Investments | $99.8M | -9.6% |
| Total Assets | $1.69B | +11.9% |
| Total Liabilities | $823.9M | +57.7% |
| Stockholders' Equity | $866.8M | -12.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$163.0M | -12.7% |
| Capital Expenditures | $10.1M | +7.4% |
| Investing Cash Flow | $181.1M | +122.5% |
| Financing Cash Flow | $3.6M | -99.4% |
| Free Cash Flow | -$173.1M | -12.4% |